CEG

Constellation Energy

$264.57

-7.09%
Sep 14, 2026
Bobby Quantitative Model
Constellation Energy Corporation is the largest operator of carbon-free nuclear power generation in the United States, producing electricity from nuclear, wind, solar, natural gas, and hydroelectric assets while selling power, natural gas, and sustainable energy solutions to utilities, municipalities, cooperatives, and commercial and industrial customers across the Mid-Atlantic, Midwest, New York, ERCOT, and other regional markets. Spun off from Exelon in early 2022, the company has quickly established itself as a distinct platform play on the convergence of nuclear baseload generation and the surging electricity demand from AI data centers, rather than a traditional regulated utility. The current investor narrative is dominated by the transformational Calpine acquisition, which management credits for a beat-and-raise quarter and roughly 20% earnings growth guidance, alongside a rapidly expanding pipeline of power purchase agreements — including 920 megawatts of new deals and a Walmart PPA — that position Constellation as a primary beneficiary of the data center power crunch. However, the stock has been weighed down by elevated debt from the Calpine deal, delayed cash flow realization, and a sharp year-to-date drawdown, creating a debate between bulls who see durable long-term growth and skeptics concerned about leverage and near-term free cash flow generation.

People also watch

Vistra

Vistra

VST

Analysis
NRG Energy

NRG Energy

NRG

Analysis
Talen Energy

Talen Energy

TLN

Analysis
Oklo

Oklo

OKLO

Analysis
NextEra Energy

NextEra Energy

NEE

Analysis

BobbyInvestment Opinion: Should I buy CEG Today?

We rate CEG a Hold. The company's unique position as the largest carbon-free nuclear operator with a 920 MW PPA pipeline and 63.9% revenue growth is compelling, but the heavy debt load from Calpine and negative free cash flow warrant caution. The analyst consensus is Buy with an average target of $348.30, implying 22.3% upside, but the stock's 22.3% YTD decline and 10.5% one-year loss suggest that near-term risks are not fully priced in.

Supporting evidence for a Hold includes: 1) Revenue growth of 63.9% YoY in Q1 2026, driven by Calpine; 2) Gross margin of 75.8% and net margin of 9.1%, indicating strong profitability; 3) Forward PE of 21.3x, which is reasonable for ~20% earnings growth guidance; 4) Analyst average target of $348.30, implying 22.3% upside; and 5) TTM free cash flow of $1.14 billion, which is positive but insufficient to quickly reduce debt. However, the debt-to-equity of 0.62 and interest expense of $253 million in Q1 2026 are red flags, and the stock's relative strength of -34.3% YTD shows it is out of favor.

The biggest risks that could invalidate the thesis are: 1) Failure to deleverage, leading to a credit downgrade and higher borrowing costs; 2) A slowdown in AI-driven power demand or delays in PPA conversions; and 3) Regulatory changes that reduce nuclear subsidies. We would upgrade to Buy if free cash flow turns sustainably positive and debt-to-equity falls below 0.5, or if the stock drops below $250 (near the 52-week low) providing a better entry point. We would downgrade to Sell if revenue growth decelerates below 10% or if the dividend is cut. At 21.3x forward earnings, the stock is fairly valued relative to its growth prospects, but the risk/reward is balanced.

Sign up to view all

CEG 12-Month Price Forecast

CEG presents a balanced risk/reward profile. The company's unmatched nuclear fleet and growing PPA pipeline position it well for the AI-driven power demand surge, but the Calpine acquisition has strained the balance sheet and free cash flow. The stock's 22.3% YTD decline reflects these concerns, yet analyst targets imply significant upside. We would upgrade to bullish if free cash flow turns sustainably positive and debt reduction accelerates, or downgrade to bearish if leverage remains elevated and growth slows. The medium confidence reflects the uncertainty around the timing of cash flow realization and the pace of AI demand.

Historical Price
Current Price $264.57
Average Target $345.00
High Target $441.00
Low Target $230.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Constellation Energy's 12-month outlook, with a consensus price target around $348.30 and implied upside of +31.6% versus the current price.

Average Target

$348.30

0 analysts

Implied Upside

+31.6%

vs. current price

Analyst Count

covering this stock

Price Range

$290 - $441

Analyst target range

Drowning in data?

Find the real signal!

Bulls vs Bears: CEG Investment Factors

The bull case rests on CEG's unique position as the largest carbon-free nuclear operator, with 63.9% revenue growth, a 920 MW PPA pipeline, and analyst targets implying 22.3% upside. The bear case highlights the heavy debt load from Calpine, negative free cash flow, and a 22.3% YTD decline that reflects deep skepticism about near-term execution. The most important tension is whether the Calpine acquisition will deliver the promised synergies and cash flow before leverage becomes a binding constraint. Currently, the bear evidence is stronger on near-term metrics (FCF, debt, relative performance), but the bull case has more long-term optionality from AI-driven power demand. The resolution of this debate hinges on the next few quarters of cash flow generation and debt reduction.

Bullish

  • Revenue growth accelerating at 63.9% YoY: Q1 2026 revenue reached $11.12 billion, up 63.9% year-over-year, driven by the Calpine acquisition and surging power demand. This is a dramatic acceleration from the 2025 quarterly run-rate of $5.5–7.2 billion, demonstrating the scale of the combined platform.
  • Analyst consensus buy with 22.3% upside: 20 analysts rate CEG a buy (mean 1.55), with an average target price of $348.30 versus the current $284.75, implying 22.3% upside. The high target of $441 suggests even greater potential if the growth narrative gains traction.
  • Massive PPA pipeline and AI power demand: The company signed 920 MW of new power purchase agreements, including a Walmart PPA, and raised guidance to ~20% earnings growth. These deals lock in long-term revenue and position CEG as a primary beneficiary of the data center power crunch.
  • Strong profitability with 75.8% gross margin: Gross margin stands at 75.8%, with a net margin of 9.1% and operating margin of 12.1%. Despite integration costs, the core nuclear fleet generates high-margin, carbon-free baseload power that is increasingly valuable.

Bearish

  • Elevated debt from Calpine acquisition: Debt-to-equity stands at 0.62, and the Calpine deal has significantly increased leverage. Interest expense in Q1 2026 was $253 million, up from $146 million in Q1 2025, pressuring free cash flow and limiting financial flexibility.
  • Negative free cash flow and delayed realization: TTM free cash flow is only $1.14 billion, and the company has been criticized for delayed cash flow realization from the Calpine deal. This raises concerns about the sustainability of the dividend and the ability to deleverage.
  • Significant underperformance versus the market: CEG is down 22.3% year-to-date and 10.5% over the past year, while the S&P 500 (SPY) is up 12.1% YTD and 16.2% over one year. Relative strength is deeply negative (-34.3% YTD), indicating a clear loss of investor confidence.
  • High valuation multiples versus utilities: Price-to-book is 7.6x and EV/EBITDA is 23.1x, both well above typical utility sector averages. These multiples leave little room for error if growth disappoints or if interest rates remain elevated.

CEG Technical Analysis

Beta

1.12

1.12x market volatility

Max Drawdown

-41.5%

Largest decline past year

52-Week Range

$229-$413

Price range past year

Annual Return

-18.2%

Cumulative gain past year

PeriodCEG ReturnS&P 500
1m-6.3%-2.0%
3m-1.3%+1.4%
6m-16.6%+15.0%
1y-18.2%+15.7%
ytd-27.8%+11.6%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

CEG Fundamental Analysis

Quarterly Revenue

$11.1B

2026-03

Revenue YoY Growth

+63.8%

YoY Comparison

Gross Margin

42.9%

Latest Quarter

Free Cash Flow

$1.1B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Constellation ERCOT
Constellation Mid Atlantic
Constellation Midwest
Constellation New York
Constellation Other Regions

Open an Account, get $2 TSLA now!

Valuation Analysis: Is CEG Overvalued?

PE

47.7x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 6x~133x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

23.1x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks are significant. The Calpine acquisition has pushed debt-to-equity to 0.62, and interest expense in Q1 2026 alone was $253 million, up 73% year-over-year. Free cash flow TTM is only $1.14 billion, which is insufficient to cover the $1.14 billion dividend (payout ratio 21%) and debt reduction, raising concerns about the sustainability of the dividend and the pace of deleveraging. Additionally, revenue is heavily concentrated in power generation, with earnings sensitive to volatile energy prices and weather, as evidenced by the swing from $0.38 EPS in Q1 2025 to $4.49 in Q1 2026. The integration of Calpine adds operational complexity and execution risk, and any delay in realizing synergies could further pressure margins and cash flow.

Market and competitive risks are also material. CEG trades at a premium to the utility sector, with a price-to-book of 7.6x and EV/EBITDA of 23.1x, leaving it vulnerable to valuation compression if growth slows or interest rates remain high. The beta of 1.12 indicates moderate market correlation, but the stock has underperformed the S&P 500 by 26.7 percentage points over the past year, reflecting sector rotation away from high-multiple utilities. Competition from other nuclear and renewable providers, such as Oklo and NuScale, could threaten CEG's pricing power, although their technologies are not yet commercially viable at scale. Regulatory support for nuclear power is a tailwind, but any change in policy or subsidies could impact profitability.

The worst-case scenario would involve a combination of operational missteps, delayed cash flow from Calpine, and a deterioration in energy prices. If free cash flow remains weak and debt reduction stalls, the stock could retest its 52-week low of $228.63, representing a 19.7% decline from the current price of $284.75. In a more severe scenario, if the company is forced to cut its dividend or if a major credit rating downgrade occurs, the stock could fall to the analyst low target of $290, which is actually above the current price, but the 52-week low is a more realistic downside reference. Given the max drawdown of 41.45% over the past year, investors could lose up to 40% from recent highs in a prolonged bear market.

FAQ

The key risks include: 1) Financial risk: High debt-to-equity of 0.62 and interest expense of $253 million in Q1 2026, which could strain cash flow and lead to a dividend cut. 2) Operational risk: Integration of Calpine may not deliver expected synergies, and earnings are volatile (EPS ranged from $0.38 to $4.49 in recent quarters). 3) Market risk: The stock has underperformed the S&P 500 by 26.7% over the past year, and its beta of 1.12 means it is sensitive to market downturns. 4) Regulatory risk: Changes in nuclear energy subsidies or power market regulations could impact profitability. The most severe risk is a credit downgrade or dividend cut, which could trigger a sharp sell-off.

Our 12-month forecast for CEG includes three scenarios: Bull case (25% probability) with a target range of $400-$441, driven by successful Calpine integration and accelerated AI demand; Base case (55% probability) with a target range of $330-$360, assuming steady execution and gradual debt reduction; and Bear case (20% probability) with a target range of $230-$290, if integration stumbles and free cash flow remains weak. The base case is most likely, aligning with the analyst average target of $348.30. The key assumption is that CEG achieves its ~20% earnings growth guidance and makes progress on deleveraging. However, if free cash flow disappoints, the bear case could gain traction.

CEG appears fairly valued to slightly overvalued on a trailing basis, but undervalued on forward estimates. The trailing PE is 47.7x, which is high, but the forward PE is 21.3x, reflecting expected earnings growth of ~20%. The price-to-book ratio of 7.6x is well above the utility sector average, and EV/EBITDA of 23.1x is also elevated. However, the PEG ratio is negative due to trailing earnings distortions, making it less useful. Compared to peers, CEG commands a premium for its carbon-free nuclear fleet and growth prospects. The market is pricing in successful Calpine integration and AI-driven demand. If these materialize, the stock could be undervalued; if not, it could be overvalued.

CEG is a good buy for long-term investors who believe in the nuclear energy growth story and are willing to accept near-term risks. The stock trades at $284.75, with analyst targets averaging $348.30 (22.3% upside) and a high target of $441. However, the company carries significant debt from the Calpine acquisition (debt-to-equity 0.62) and has negative free cash flow trends, which could pressure the stock if integration disappoints. The 22.3% YTD decline and 10.5% one-year loss indicate that the market is skeptical. For risk-averse investors, waiting for clearer signs of deleveraging and positive free cash flow may be prudent. Overall, it's a speculative buy for those with a high risk tolerance and a 3-5 year horizon.

CEG is more suitable for long-term investment (3-5 years) rather than short-term trading. The company is in a growth phase, integrating a major acquisition and capitalizing on secular trends in AI power demand. The dividend yield is low (0.44%), so income is not a primary return driver. The stock's beta of 1.12 and recent volatility (max drawdown 41.45%) make it risky for short-term traders. Earnings visibility is improving but still uncertain due to integration risks. A minimum holding period of 2-3 years is recommended to allow for Calpine synergies to materialize and debt to be reduced. Short-term traders might find opportunities around earnings announcements, but the overall thesis is long-term.